NCT01276327View on ClinicalTrials.gov

Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

May 31, 2011

Conditions
Healthy
Interventions
DRUG

Linagliptin + Pioglitazone

Medium doses, oral administration

DRUG

Linagliptin + Pioglitazone

Medium doses, oral administration

DRUG

Linagliptin/Pioglitazone

Medium dose oral administration

DRUG

Linagliptin/Pioglitazone

Medium dose oral administration

Trial Locations (1)

Unknown

1264.14.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY